AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Ladero, JM
Citation: Jm. Ladero, Recurring hepatic hydrothorax: a difficult therapeutic challenge, REV ESP E D, 93(9), 2001, pp. 564-565

Authors: Martinez, C Garcia-Martin, E Ladero, JM Sastre, J Garcia-Gamito, F Diaz-Rubio, M Agundez, JAG
Citation: C. Martinez et al., Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk, CARCINOGENE, 22(8), 2001, pp. 1323-1326

Authors: Garcia-Martin, E Martinez, C Ladero, JM Gamito, FJG Agundez, JAG
Citation: E. Garcia-martin et al., High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population, EUR J CL PH, 57(1), 2001, pp. 47-49

Authors: Agundez, JAG Gallardo, L Ledesma, MC Lozano, L Rodriguez-Lescure, A Pontes, JC Iglesias-Moreno, MC Poch, J Ladero, JM Benitez, J
Citation: Jag. Agundez et al., Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients, ONCOL-BASEL, 61(1), 2001, pp. 59-63

Authors: Ladero, JM
Citation: Jm. Ladero, Use of antioxidants to treat pain in patients with acute pancreatitis, REV ESP E D, 92(6), 2000, pp. 373-374

Authors: Marcus, PM Hayes, RB Vineis, P Garcia-Closas, M Caporaso, NE Autrup, H Branch, RA Brockmoller, J Ishizaki, T Karakaya, AE Ladero, JM Mommsen, S Okkels, H Romkes, M Roots, I Rothman, N
Citation: Pm. Marcus et al., Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction, CANC EPID B, 9(5), 2000, pp. 461-467

Authors: Agundez, JAG Lozano, L Ladero, JM Sastre, J Cerdan, FJ Diaz-Rubio, M Benitez, J
Citation: Jag. Agundez et al., N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?, SC J GASTR, 35(10), 2000, pp. 1087-1091

Authors: Agundez, JAG Jimenez-Jimenez, FJ Luengo, A Molina, JA Orti-Pareja, M Vazquez, A Ramos, F Duarte, J Coria, F Ladero, JM Alvarez-Cermeno, JC Benitez, J
Citation: Jag. Agundez et al., Slow allotypic variants of the NAT2 gene and susceptibility to early-onsetParkinson's disease, NEUROLOGY, 51(6), 1998, pp. 1587-1592
Risultati: 1-8 |